
Loading, please wait...

Loading, please wait...

Experts estimated the incidence of remote unprovoked seizures (RS) & drug-resistant epilepsy (DRE) in first-ever status epilepticus (SE) survivors. Data from 279 SE patients were analyzed. RS risk was 20.4%, associated with specific etiologies and SE semiology. Super-refractory SE and non-convulsive SE evolution were linked to DRE. RS risk after SE was moderate, confined within 2 years, and influenced by specific etiologies & SE characteristics.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Experts estimated the incidence of remote unprovoked seizures (RS) & drug-resistant epilepsy (DRE) in first-ever status epilepticus (SE) survivors. Data from 279 SE patients were analyzed. RS risk was 20.4%, associated with specific etiologies and SE semiology. Super-refractory SE and non-convulsive SE evolution were linked to DRE. RS risk after SE was moderate, confined within 2 years, and influenced by specific etiologies & SE characteristics.
2 months ago

An elderly man with partially repaired Tetralogy of Fallot presented with STEMI caused by coronary embolism rather than atherosclerosis. Successful treatment with sustained mechanical aspiration thrombectomy underscores the vital need for high clinical vigilance in adult congenital heart disease.
Today

Demanding exhaustive hormonal profiling can inadvertently discourage clinical studies involving females. Methodological standards must align with the specific scientific question to expand, not restrict, equitable evidence for women.
Today

A recent study demonstrates that spinal oxygen sensors do not require mitochondrial electron transport to trigger sympathetic excitation during acute hypoxia, revealing new insights into how mitochondrial oxidative stress modulates autonomic tone in cardiovascular and neurological diseases.
Today

A comparative review of tension band wiring and intramedullary screw fixation in thumb metacarpophalangeal arthrodesis, evaluating union rates, hardware complications, and clinical outcomes.
Today

Following regulatory scrutiny from FSSAI regarding promotional representations and lean muscle preservation claims, Dr. Reddy's Laboratories and Nestlé Health Science are currently reviewing the branding and marketing strategy for their joint nutritional supplement Celevida GLP+.
Today